AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 126 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $370,812 | -42.5% | 58,121 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $644,562 | -27.8% | 58,121 | 0.0% | 0.01% | -33.3% |
| Q1 2023 | $892,157 | -30.8% | 58,121 | 0.0% | 0.01% | -29.4% |
| Q4 2022 | $1,289,705 | +107.3% | 58,121 | +52.6% | 0.02% | +88.9% |
| Q3 2022 | $622,000 | -79.6% | 38,088 | -70.2% | 0.01% | -79.5% |
| Q4 2021 | $3,043,000 | -3.5% | 128,000 | 0.0% | 0.04% | -13.7% |
| Q3 2021 | $3,153,000 | -0.3% | 128,000 | 0.0% | 0.05% | -13.6% |
| Q2 2021 | $3,163,000 | +13.3% | 128,000 | 0.0% | 0.06% | -4.8% |
| Q1 2021 | $2,792,000 | -14.5% | 128,000 | 0.0% | 0.06% | -28.7% |
| Q4 2020 | $3,267,000 | -32.9% | 128,000 | -26.0% | 0.09% | -45.6% |
| Q3 2020 | $4,869,000 | +37.8% | 172,978 | +38.4% | 0.16% | +14.3% |
| Q2 2020 | $3,533,000 | – | 125,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |